VSTM
Verastem Inc
NASDAQ: VSTM · HEALTHCARE · BIOTECHNOLOGY
$5.40
-1.10% today
Updated 2026-04-29
Market cap
$479.62M
P/E ratio
—
P/S ratio
15.51x
EPS (TTM)
$-3.02
Dividend yield
—
52W range
$4 – $11
Volume
2.0M
Verastem Inc (VSTM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $26.72M | $17.46M | $88.52M | $2.05M | $2.60M | $0.00 | $10.00M | $30.91M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | -34.7% | +407.1% | -97.7% | +26.4% | -100.0% | — | +209.1% |
| Cost of revenue | — | — | $0.00 | $0.00 | $0.00 | $754000.00 | $670000.00 | $556000.00 | $588000.00 | $2.81M | $33.74M | $206000.00 | $118000.00 | $62000.00 | $26000.00 | $5.30M |
| Gross profit | — | — | $0.00 | $0.00 | $0.00 | $-754000.00 | $-670000.00 | $-556000.00 | $26.13M | $14.65M | $54.77M | $2.05M | $2.60M | $-62000.00 | $10.00M | $25.62M |
| Gross margin | — | — | — | — | — | — | — | — | 97.8% | 83.9% | 61.9% | 100.0% | 100.0% | — | 100.0% | 82.9% |
| R&D | $400000.00 | $9.88M | $21.71M | $25.93M | $35.45M | $40.56M | $19.78M | $46.42M | $43.65M | $45.78M | $41.38M | $39.35M | $50.56M | $61.36M | $81.33M | $114.60M |
| SG&A | — | $3.81M | $10.52M | $15.47M | $18.16M | $17.63M | $17.22M | $21.38M | $77.27M | $101.21M | $62.76M | $24.11M | $24.98M | $28.20M | $43.62M | $81.15M |
| Operating income | $-784000.00 | $-13.70M | $-32.23M | $-41.40M | $-53.61M | $-58.20M | $-37.00M | $-67.80M | $-94.78M | $-132.34M | $-49.36M | $-61.41M | $-72.94M | $-92.08M | $-114.96M | $-170.13M |
| Operating margin | — | — | — | — | — | — | — | — | -354.8% | -758.1% | -55.8% | -2991.2% | -2809.6% | — | -1149.6% | -550.3% |
| EBITDA | $-784000.00 | $-13.62M | $-31.78M | $-40.97M | $-52.94M | $-57.45M | $-35.77M | $-66.69M | $-65.20M | $-126.42M | $-50.48M | $-61.16M | $-71.56M | $-83.17M | $-125.86M | $-170.13M |
| EBITDA margin | — | — | — | — | — | — | — | — | -244.0% | -724.2% | -57.0% | -2978.9% | -2756.4% | — | -1258.6% | -550.3% |
| EBIT | — | $-13.70M | $-31.98M | $-41.20M | $-53.37M | $-58.20M | $-36.44M | $-67.24M | $-66.62M | $-128.60M | $-51.74M | $-61.23M | $-71.67M | $-83.23M | $-125.89M | $-170.86M |
| Interest expense | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $559000.00 | $5.81M | $20.61M | $15.79M | $9.97M | $2.14M | $4.14M | $4.56M | $1.14M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-786000.00 | $-13.68M | $-31.98M | $-41.20M | $-53.37M | $-57.87M | $-36.44M | $-67.80M | $-72.43M | $-149.21M | $-67.73M | $-71.20M | $-73.81M | $-87.37M | $-130.64M | $-209.47M |
| Net income growth (YoY) | — | -1640.8% | -133.7% | -28.8% | -29.5% | -8.4% | +37.0% | -86.1% | -6.8% | -106.0% | +54.6% | -5.1% | -3.7% | -18.4% | -49.5% | -60.3% |
| Profit margin | — | — | — | — | — | — | — | — | -271.1% | -854.8% | -76.5% | -3468.1% | -2843.3% | — | -1306.4% | -677.6% |